ACB
BNCL

Aristotle Capital Boston’s Beneficial Bancorp, Inc. BNCL Stock Holding History

Aristotle Capital Boston’s Portfolio BNCL Stock Details BNCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-150,859
Closed -$2.16M – 125
2018
Q4 		$2.16M Buy
150,859
+33,307
+28% +$516K 0.18% 112
2018
Q3 		$1.99M Buy
117,552
+11,598
+11% +$198K 0.15% 116
2018
Q2 		$1.72M Sell
105,954
-402,193
-79% -$6.52M 0.14% 116
2018
Q1 		$7.9M Buy
508,147
+158,313
+45% +$2.52M 0.37% 102
2017
Q4 		$5.75M Buy
349,834
+110,145
+46% +$1.83M 0.42% 101
2017
Q3 		$3.98M Buy
239,689
+112,421
+88% +$1.71M 0.36% 99
2017
Q2 		$1.91M Buy
127,268
+75,122
+144% +$1.16M 0.21% 110
2017
Q1 		$834K Buy
52,146
+4,853
+10% +$82.1K 0.11% 115
2016
Q4 		$870K Buy
+47,293
New +$773K 0.12% 112
2016
Q2 		– Sell
-410
Closed -$6K – 118
2016
Q1 		$6K Buy
+410
New +$5.3K ﹤0.01% 112

Aristotle Capital Boston's BNCL Position: Q1 2019 in Review

Aristotle Capital Boston sold out of Beneficial Bancorp, Inc. (BNCL) in Q1 2019, closing a stake of 150,859 shares — an estimated $2.16M sold.

Aristotle Capital Boston first reported a position in BNCL in Q1 2016 and held it in 10 quarters. The position peaked at $7.9M in Q1 2018. 0 funds tracked by Wall St. Rank hold BNCL as of Q1 2019.

  • Aristotle Capital Boston reported no remaining Beneficial Bancorp, Inc. position as of Q1 2019 after selling out during the quarter.
  • Aristotle Capital Boston sold 150,859 Beneficial Bancorp, Inc. shares in Q1 2019, an estimated $2.16M.
  • Aristotle Capital Boston first reported a position in Beneficial Bancorp, Inc. in Q1 2016 and held it in 10 quarters.
  • Aristotle Capital Boston's Beneficial Bancorp, Inc. position peaked at $7.9M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Beneficial Bancorp, Inc. as of Q1 2019.

Based on Aristotle Capital Boston's 13F filing for Q1 2019, filed 15 May 2019.